Birth control pills are widely recognized as one of the most effective contraceptive methods. But did you know? Short-acting oral contraceptives also have other clever uses—though these require specific methods. Say Goodbye to Period Pain: Top 10 Secret Benefits of Birth Control Pills (Public Health Network) 1. Relieve Menstrual Cramps Taking birth control pills cyclically suppresses ovulation and alleviates period pain, with high effectiveness.However, young girls experiencing menstrual pain should avoid using birth control pills, as they may disrupt the body's natural hormonal regulation and balance. 2. Delaying Menstruation Avoid overuse, as birth control pills may interfere with the body's hormonal feedback and balance mechanisms, artificially disrupting the natural cycle and causing menstrual irregularities.Occasional use is generally not problematic. Using progesterone (e.g., progesterone tablets) is preferable to oral contraceptives.
III. Pregnancy Testing
In addition to urine tests, blood tests, and ultrasounds, oral contraceptives can be used for a withdrawal bleeding test (progesterone is commonly preferred). Take 3 tablets three times daily for two days.If not pregnant, bleeding should occur around 3 days after discontinuation. If no bleeding occurs within 7 days, pregnancy is likely. This method is reportedly harmful to the fetus and should only be used when pregnancy is definitely not desired. IV. Menstrual Regulation for Menopausal Dysfunctional Uterine Bleeding For late-stage menopausal dysfunctional uterine bleeding, I generally avoid contraceptive pills unless there is menorrhagia or metrorrhagia.Since contraceptive pills contain both estrogen and progesterone, they induce artificial menstruation even when the ovaries have ceased hormone production. This can persist into one's sixties or seventies, which is quite bothersome.At this stage, I often employ progesterone alone for cyclical treatment. This cleverly exploits progesterone's unique property: without prior estrogen preparation, progesterone alone does not induce withdrawal bleeding.Therefore, if bleeding does not occur after progesterone administration, it indicates the ovaries have ceased estrogen production. This allows discontinuation of the cumbersome cyclical therapy. Moreover, since ovarian function is absent, the dysfunctional uterine bleeding will never recur—how ingenious!
V. Suboptimal Menstrual Regulation
While monthly medication may produce apparent "menstruation" with light flow, patients often mistakenly believe their condition is cured. However, symptoms frequently recur after discontinuing treatment. This is because dysfunctional uterine bleeding, especially during adolescence and menopause, is predominantly caused by anovulatory cycles—accounting for 80-90% of cases.To achieve a complete cure for dysfunctional uterine bleeding, it is essential to establish normal ovulatory function, which is critically important during adolescence. However, the pharmacological action of contraceptives specifically suppresses ovulation. Therefore, using contraceptives to treat dysfunctional uterine bleeding or regulate menstruation will only further inhibit ovulation. Strictly speaking, this is not treating the condition but rather adding fuel to the fire! I do not advocate the use of contraceptives for menstrual regulation in women of childbearing age; they are only suitable for menopause.
VI. Reducing Menstrual Flow
Cyclic contraceptive use can decrease menstrual flow and shorten the period. For exceptionally heavy flow, alternative dosing methods can be employed, such as starting medication on the second day of menstruation or even the first day.This alters the standard 22-day regimen. Starting on day two requires approximately 26 days of medication. The goal is to allow a three-day break for bleeding, aligning with a 30-day cycle. For heavy flow, increase to 2-3 tablets nightly. Once bleeding begins to decrease, gradually reduce the dose to one tablet nightly and maintain this level.Do not wait until bleeding has significantly decreased before reducing the dose (as the medication has a lingering effect). This approach reduces the total dosage required. Ideally, the issue should be resolved with the lowest effective dose, as contraceptive pills are not entirely without side effects.Low-dose cyclic therapy can treat metrorrhagia. However, diagnosing "metrorrhagia" requires ruling out tumors, especially endometrial adenocarcinoma (uterine body cancer) in elderly women. Avoid blind medication that delays optimal treatment timing. Contraceptives can also be used for "medically induced curettage" for metrorrhagia, but seek qualified medical professionals—never self-administer.
VIII. Hemostasis for Heavy Functional Uterine Bleeding
Short-acting contraceptives achieve over 90% success in stopping bleeding from functional uterine bleeding (abbreviated as "FUB," not "GUB"). Dosage varies by condition. Typically, one to two tablets daily for three to five days yields results. For severe cases, increase dosage, ideally every 8 to 12 hours.Duration of use is crucial. Since bleeding often resumes upon discontinuation, we naturally wish to avoid immediate recurrence after stopping. Therefore, extend the medication course to over 20 days, delaying the next menstrual cycle by approximately one month. For heavy bleeding, there's no need to strictly follow the textbook recommendation of starting on the fifth day. Begin treatment within the first one or two days of bleeding—the sooner you start, the sooner the bleeding stops. Why not?
IX. Alleviating Endometriosis
No longer used due to the availability of better medications.
X. Preventing Pelvic Infections
Reportedly prevents pelvic infections. Taking it for over a year is said to reduce adnexitis by two-thirds, cut ectopic pregnancies by 90%, decrease breast tumors by 10%–75%, lower ovarian cancer risk by one-third, and halve endometriosis cases.Regarding breast cancer, some reports indicate an increase, while others suggest a 10% reduction. Opinions also vary on its effects against myocardial infarction, hypertension, and venous thrombosis—no consensus has been reached to date.